top of page
diasorin-banner-1536x317.jpg

LIAISON® MeMed BV®

The new test enables physicians to accurately differentiate between bacterial and viral infections, thus supporting fast and more-informed treatment and patient management decisions. This innovative solution is now available on the DiaSorin LIAISON® XL and LIAISON® XS analyzers.

liasion.jpg

Accurately distinguishes between bacterial and viral infections

DiaSorin’s high-throughput, high-quality chemiluminescent assay easily identifies the source of a patient’s infection using the LIAISON® XL and LIAISON® XS automated analyzers.

diasorin-fact-sheet.jpg

The clinical performance of LIAISON® MeMed BV® has been confirmed in validation based on testing with patients with signs and symptoms suggestive of acute bacterial or viral infection. Measures of Sensitivity, Specificity, and Negative Positive Value (NPV) have been calculated by considering a bacterial result as positive and a viral/other result as negative.

performances-2048x655.jpg
results-1.jpg

For more educational resources or product discussions please contact info.canada@diasorin.com

 

Or email directly to:
 

Nezar Rghei

Scientific Liaison & MeMed BV Program Lead

DiaSorin Canada Inc.

M: 905.980.1938

bottom of page